PD-1 Inactivated TIL Cell Therapy (IOV-4001): Results are anticipated in the second half of 2025 from the Phase 2 efficacy portion of the IOV-GM1-201 trial in previously treated advanced melanoma.

Donald Trump took to Truth Social Thursday to demand the immediate resignation of Intel CEO Lip-Bu Tan. “The CEO of INTEL is ...

Epstein has been at the forefront of a lot of people’s minds after the Justice Department clawed back the release of the ...